Key Points
-
Characteristic oro-facial signs are prominent features of Kawasaki disease
-
The patient may first seek treatment by a dental practitioner
-
Morbidity and mortality can be reduced by early recognition and appropriate treatment
-
Antibiotic cover is needed in patients with heart valve damage caused by Kawasaki disease
-
Kawasaki disease may re-occur.
Abstract
Kawasaki disease (mucocutaneous lymph node syndrome) is a disease of unknown aetiology characterised by vasculitis which may affect the coronary arteries. Young children are most commonly affected although the disease has been described in adults. We report a case of recurrent Kawasaki disease which presented to an oral medicine clinic, where early recognition prompted appropriate management.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Kawasaki T . Acute febrile mucocutaneous lymph node syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Jpn J Allergy 1967; 16: 178–222.
Dajani A S, Taubert K A, Gerber M A et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993; 87: 1776–1780.
Curtis N . Kawasaki disease. BMJ 1997; 315: 322–323.
Ogden G R, Kerr M . Mucocutaneous lymph node syndrome (Kawasaki disease). Oral Surg Oral Med Oral Pathol 1989; 67: 569–572.
Thompson A C, Lamey P J . Kawasaki syndrome in an adult. J Laryngol Otol 1990; 104: 569–572.
Dhillon R, Newton L, Rudd P T, Hall S M . Management of Kawasaki disease in the British Isles. Arch Dis Child 1993; 69: 631–636.
Kato H, Akagi T, Sugimura T et al. Kawasaki disease. Coron Artery Dis 1995; 6: 194–206.
Rowley A H, Gonzalez C F, Gidding S S, Duffy C E, Shulman S T . Incomplete Kawasaki disease with coronary artery involvement. J Paediatr 1987; 110: 409–413.
Akagi T, Kato H, Inoue O, Sato N, Imamura K . Valvular heart disease in Kawasaki syndrome: Incidence and natural history. Am Heart J 1990; 120: 366–372.
Newburger J W . Treatment of Kawasaki disease. Lancet 1996; 347: 1128.
Bell D M, Morens D M, Holman R C, Hurwitz E S, Hunter M K . Kawasaki syndrome in the United States. Am J Dis Child 1983; 137: 211–214.
Yanagawa H, Nakamura Y, Yashiro M, Hirose K . Results of 12 nationwide surveys of Kawasaki disease. In Kato H (ed) Kawasaki disease. pp 3–14. Amsterdam: Elsevier Science, 1995.
Nakamura Y, Yanagawa H . A case-control study of recurrent Kawasaki disease using the database of the nationwide surveys in Japan. Eur J Pediatr 1996; 155: 303–307.
Author information
Authors and Affiliations
Additional information
Refereed paper
Rights and permissions
About this article
Cite this article
Pemberton, M., Doughty, I., Middlehurst, R. et al. Recurrent Kawasaki disease. Br Dent J 186, 270–271 (1999). https://doi.org/10.1038/sj.bdj.4800085
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bdj.4800085
This article is cited by
-
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature
Italian Journal of Pediatrics (2021)
-
Letters
British Dental Journal (1999)
